161 related articles for article (PubMed ID: 12213403)
21. Modeling the Cost of Vaccinating a Measles Zero-Dose Child in Zambia Using Three Vaccination Strategies.
Mak J; Patenaude BN; Mutembo S; Pilewskie ME; Winter AK; Moss WJ; Carcelen AC
Am J Trop Med Hyg; 2024 Jul; 111(1):121-128. PubMed ID: 38772386
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness analysis of an intervention project engaging Traditional and Religious Leaders to improve uptake of childhood immunization in southern Nigeria.
Oyo-Ita AE; Hanlon P; Nwankwo O; Bosch-Capblanch X; Arikpo D; Esu E; Auer C; Meremikwu M
PLoS One; 2021; 16(9):e0257277. PubMed ID: 34529714
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of supplementary immunization for measles in India.
Dabral M
Indian Pediatr; 2009 Nov; 46(11):957-62. PubMed ID: 19578225
[TBL] [Abstract][Full Text] [Related]
24. Global eradication of measles: an epidemiologic and economic evaluation.
Levin A; Burgess C; Garrison LP; Bauch C; Babigumira J; Simons E; Dabbagh A
J Infect Dis; 2011 Jul; 204 Suppl 1():S98-106. PubMed ID: 21666220
[TBL] [Abstract][Full Text] [Related]
25. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
Thompson KM; Badizadegan ND
Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
[TBL] [Abstract][Full Text] [Related]
26. USA supports measles elimination.
EPI Newsl; 1996 Jun; 18(3):1. PubMed ID: 12347182
[TBL] [Abstract][Full Text] [Related]
27. A benefit-cost analysis of two-dose measles immunization in Canada.
Pelletier L; Chung P; Duclos P; Manga P; Scott J
Vaccine; 1998; 16(9-10):989-96. PubMed ID: 9682349
[TBL] [Abstract][Full Text] [Related]
28. The laboratory confirmation of suspected measles cases in settings of low measles transmission: conclusions from the experience in the Americas.
Dietz V; Rota J; Izurieta H; Carrasco P; Bellini W
Bull World Health Organ; 2004 Nov; 82(11):852-7. PubMed ID: 15640921
[TBL] [Abstract][Full Text] [Related]
29. Strategic planning for measles control: using data to inform optimal vaccination strategies.
Simons E; Mort M; Dabbagh A; Strebel P; Wolfson L
J Infect Dis; 2011 Jul; 204 Suppl 1():S28-34. PubMed ID: 21666174
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of three different vaccination strategies against measles in Zambian children.
Dayan GH; Cairns L; Sangrujee N; Mtonga A; Nguyen V; Strebel P
Vaccine; 2004 Jan; 22(3-4):475-84. PubMed ID: 14670330
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of vaccination policies. The case of measles].
Lafarge H; Levy E; Rey M
Rev Epidemiol Sante Publique; 1985; 33(3):182-93. PubMed ID: 4081224
[TBL] [Abstract][Full Text] [Related]
32. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
Zhou F; Reef S; Massoudi M; Papania MJ; Yusuf HR; Bardenheier B; Zimmerman L; McCauley MM
J Infect Dis; 2004 May; 189 Suppl 1():S131-45. PubMed ID: 15106102
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of measles outbreak intervention strategies.
Shiell A; Jorm LR; Carruthers R; Fitzsimmons GJ
Aust N Z J Public Health; 1998 Feb; 22(1):126-32. PubMed ID: 9599864
[TBL] [Abstract][Full Text] [Related]
34. [Effectiveness, population-level effects, and heath economics of measles and rubella vaccination].
Wichmann O; Ultsch B
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1260-9. PubMed ID: 23990088
[TBL] [Abstract][Full Text] [Related]
35. Summary of Caribbean managers meeting.
EPI Newsl; 1994 Dec; 16(6):1-4. PubMed ID: 12288496
[TBL] [Abstract][Full Text] [Related]
36. Progress toward interrupting indigenous measles transmission--Region of the Americas, January 1999-September 2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Nov; 49(43):986-90. PubMed ID: 11098862
[TBL] [Abstract][Full Text] [Related]
37. Measles and Measles Vaccination: A Review.
Bester JC
JAMA Pediatr; 2016 Dec; 170(12):1209-1215. PubMed ID: 27695849
[TBL] [Abstract][Full Text] [Related]
38. Progress toward measles elimination--European Region, 2005--2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(6):142-5. PubMed ID: 19229166
[TBL] [Abstract][Full Text] [Related]
39. Economic analysis of the 1996-1997 mass measles immunization campaigns in South Africa.
Uzicanin A; Zhou F; Eggers R; Webb E; Strebel P
Vaccine; 2004 Sep; 22(25-26):3419-26. PubMed ID: 15308367
[TBL] [Abstract][Full Text] [Related]
40. Is global measles eradication feasible?
de Quadros CA
Curr Top Microbiol Immunol; 2006; 304():153-63. PubMed ID: 16989269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
